14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of MCRB
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Big movements in Seres Therapeutics stock price on Monday moving 18.52% between high and low
(Updated on May 06, 2024)

Buy or Hold candidate since Apr 26, 2024 Gain 44.24% PDF

The Seres Therapeutics stock price gained 2.59% on the last trading day (Monday, 6th May 2024), rising from $1.16 to $1.19. It has now gained 8 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 18.52% from a day low at $1.08 to a day high of $1.28. The price has risen in 9 of the last 10 days and is up by 90.52% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 2 million more shares were traded than the day before. In total, 6 million shares were bought and sold for approximately $7.11 million.

Given the current short-term trend, the stock is expected to fall -22.18% during the next 3 months and, with a 90% probability hold a price between $0.388 and $0.93 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

MCRB Signals & Forecast

Mostly positive signals in the chart today. The Seres Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $1.04 and $0.784. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, April 19, 2024, and so far it has risen 112.54%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Seres Therapeutics stock

Seres Therapeutics finds support from accumulated volume at $1.14 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.200 between high and low, or 18.52%. For the last week, the stock has had daily average volatility of 14.59%.

The Seres Therapeutics stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs. Since the Seres Therapeutics has been rising for 8 days in a row, the risk over the next couple of days has increased. We don't expect a major reaction as the stock is in very good shape technically, and therefore hold a positive evaluation despite the very short term risk.

Our recommended stop-loss: $1.15 (-3.28%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 86 and this increases the risk substantially. There is a buy signal from a pivot bottom found 11 days ago.)

Trading Expectations (MCRB) For The Upcoming Trading Day Of Tuesday 7th

For the upcoming trading day on Tuesday, 7th we expect Seres Therapeutics to open at $1.18, and during the day (based on 14 day Average True Range), to move between $1.09 and $1.29, which gives a possible trading interval of +/-$0.0983 (+/-8.26%) up or down from last closing price. If Seres Therapeutics takes out the full calculated possible swing range there will be an estimated 16.52% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.23 (3.36%) than the support at $1.14 (4.20%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Earnings coming up

Seres Therapeutics will release earnings BMO on Tuesday, May 14, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.360. We will update the financials statements for Seres Therapeutics, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 18.42% in the first trading day after earnings release.

Is Seres Therapeutics stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

Current score: 3.625 Buy Candidate Unchanged

Predicted Opening Price for Seres Therapeutics of Tuesday, May 7, 2024

Fair opening price May 7, 2024 Current price
$1.18 ( 0.560%) $1.19

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for MCRB

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.38 16.25 %
R2 1.31 9.83 %
R1 1.26 5.86 %
Current price: 1.19
Support S1 1.11 -6.98 %
S2 1.06 -10.95 %
S3 0.98 -17.37 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 1.23 3.36 %
Current price 1.19
Support S1 1.14 -4.20%
S2 1.06 -10.92%
S3 1.01 -15.13%

FAQ

What is the symbol for Seres Therapeutics Stock and on which exchange is it traded?
The symbol for Seres Therapeutics is MCRB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Seres Therapeutics Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

How to buy Seres Therapeutics Stock?
Seres Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Seres Therapeutics Stock.

What's the current price of Seres Therapeutics Stock?
As of the end of day on the May 06, 2024, the price of an Seres Therapeutics (MCRB) share was $1.19.

What is the 52-week high and low for Seres Therapeutics Stock?
The 52-week high for Seres Therapeutics Stock is $6.26 and the 52-week low is $0.540.

What is the market capitalization of Seres Therapeutics Stock?
As of the May 06, 2024, the market capitalization of Seres Therapeutics is 179.701M.

When is the next earnings date for Seres Therapeutics?
The upcoming earnings date for Seres Therapeutics is May 14, 2024.
Click to get the best stock tips daily for free!

About Seres Therapeutics

Seres Therapeutics Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the treatment of clostridium difficile infection (CDI). It is also developing SER-155, a cultivated bacteri... MCRB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT